​

Sensei Biotherapeutics (SNSE) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

SNSE Stock Forecast

Sensei Biotherapeutics (SNSE) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $50.00, with a high of $50.00 and a low of $50.00. This represents a 363.39% increase from the last price of $10.79.

- $10 $20 $30 $40 $50 High: $50 Avg: $50 Low: $50 Last Closed Price: $10.79

SNSE Stock Rating

Sensei Biotherapeutics stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (66.67%), 2 Hold (33.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 2 4 0 Strong Sell Sell Hold Buy Strong Buy

SNSE Price Target Upside V Benchmarks

TypeNameUpside
StockSensei Biotherapeutics363.39%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts111
Avg Price Target$50.00$50.00$50.00
Last Closing Price$10.79$10.79$10.79
Upside/Downside363.39%363.39%363.39%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26-4---4
May, 26-11--2
Apr, 26-11--2
Jan, 26--1--1
Dec, 25--1--1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 28, 2026Christopher LiuLoop Capital Markets$50.00$16.65200.30%363.39%
May 13, 2024Sudan LoganathanStephens$5.00$1.57218.47%-53.66%
Dec 13, 2022Citigroup$6.00$1.74244.83%-44.39%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 11, 2026BTIGBuyinitialise
Jun 04, 2026Cantor FitzgeraldOverweightOverweighthold
May 29, 2026Cantor FitzgeraldOverweightinitialise
May 22, 2026CitigroupBuyBuyinitialise
Oct 30, 2025H.C. WainwrightBuyNeutraldowngrade
Aug 05, 2025H.C. WainwrightBuyBuyhold
May 13, 2024StephensOverweightinitialise
Dec 13, 2022CitigroupBuyinitialise
Oct 03, 2022OppenheimerOutperformupgrade

Financial Forecast

EPS Forecast

$-20 $-16 $-12 $-8 $-4 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.22$-1.20$-16.72---
Avg Forecast$-1.23$-1.17$-0.63$-0.66$-0.78$-0.81
High Forecast$-1.22$-1.14$-0.32$-0.61$-0.78$-0.81
Low Forecast$-1.23$-1.19$-1.03$-0.70$-0.78$-0.81
Surprise %-0.81%2.56%2553.97%---

Revenue Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast------
High Forecast------
Low Forecast------
Surprise %------

Net Income Forecast

$-35M $-29M $-23M $-17M $-11M $-5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-34.10M$-30.16M$-21.09M---
Avg Forecast$-34.24M$-32.47M$-26.75M$-18.31M$-21.80M$-22.64M
High Forecast$-34.10M$-31.78M$-8.95M$-17.05M$-21.80M$-22.64M
Low Forecast$-34.38M$-33.17M$-28.90M$-19.57M$-21.80M$-22.64M
Surprise %-0.41%-7.13%-21.19%---

SNSE Forecast FAQ

Is Sensei Biotherapeutics stock a buy?

Sensei Biotherapeutics stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Sensei Biotherapeutics is a favorable investment for most analysts.

What is Sensei Biotherapeutics's price target?

Sensei Biotherapeutics's price target, set by 6 Wall Street analysts, averages $50 over the next 12 months. The price target range spans from $50 at the low end to $50 at the high end, suggesting a potential 363.39% change from the previous closing price of $10.79.

How does Sensei Biotherapeutics stock forecast compare to its benchmarks?

Sensei Biotherapeutics's stock forecast shows a 363.39% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Sensei Biotherapeutics over the past three months?

  • June 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Sensei Biotherapeutics’s EPS forecast?

Sensei Biotherapeutics's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.66, marking a -96.05% decrease from the reported $-16.72 in 2025. Estimates for the following years are $-0.78 in 2027, and $-0.81 in 2028.

What is Sensei Biotherapeutics’s revenue forecast?

Sensei Biotherapeutics's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $0, and $0 for 2028.

What is Sensei Biotherapeutics’s net income forecast?

Sensei Biotherapeutics's net income forecast for the fiscal year ending in December 2026 stands at $-18.309M, representing a -13.17% decrease from the reported $-21.085M in 2025. Projections indicate $-21.803M in 2027, and $-22.642M in 2028.